InMed Pharmaceuticals Announces the Appointment of Dr. SazzadHossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
TSX:IN OTCQX:IMLFF VANCOUVER, Jan. 11, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical...




